APA (7th ed.) Citation

Hüttner, F., Probst, P., Kalkum, E., Hackbusch, M., Jensen, K., Ulrich, A., . . . Diener, M. K. (2018). Addition of platinum derivatives to neoadjuvant single-agent fluoropyrimidine chemoradiotherapy in patients with stage II/III rectal cancer: Protocol for a systematic review and meta-analysis (PROSPERO CRD42017073064). Biomed Central. https://doi.org/10.1186/s13643-018-0678-9

Chicago Style (17th ed.) Citation

Hüttner, Felix, Pascal Probst, Eva Kalkum, Matthes Hackbusch, Katrin Jensen, Alexis Ulrich, Markus W. Büchler, and Markus K. Diener. Addition of Platinum Derivatives to Neoadjuvant Single-agent Fluoropyrimidine Chemoradiotherapy in Patients with Stage II/III Rectal Cancer: Protocol for a Systematic Review and Meta-analysis (PROSPERO CRD42017073064). London: Biomed Central, 2018. https://doi.org/10.1186/s13643-018-0678-9.

MLA (9th ed.) Citation

Hüttner, Felix, et al. Addition of Platinum Derivatives to Neoadjuvant Single-agent Fluoropyrimidine Chemoradiotherapy in Patients with Stage II/III Rectal Cancer: Protocol for a Systematic Review and Meta-analysis (PROSPERO CRD42017073064). Biomed Central, 2018. https://doi.org/10.1186/s13643-018-0678-9.